Wednesday, March 17, 2021
Friday, March 05, 2021
Allergan announced that it has submitted a new drug application to the FDA for investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia. The FDA is expected to act on the NDA by the end of 2021.
Tuesday, March 02, 2021
Upon examining the effects of exposure to high-dose sex steroid hormones, researchers recently observed improvement in tear function test results following the use of estradiol. They noted that the use of estradiol during menopause could improve dry eye symptoms in patients.
Corneal nerves are sometimes cut when the flap is made during LASIK. Fortunately, treatment with a nerve growth factor (NGF) has demonstrated the ability to both stimulate corneal nerve regeneration and potentially treat dry eye, a common postoperative complication of LASIK. Researchers recently studied its effects and found that NGF had “an obvious effect” on nerve repair and a potential for improvement of dry eye symptoms.